Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioharvest Sciences (BHST) Debt to Equity (2023 - 2025)

Bioharvest Sciences has reported Debt to Equity over the past 3 years, most recently at $0.01 for Q4 2025.

  • For Q4 2025, Debt to Equity fell 99.8% year-over-year to $0.01; the TTM value through Dec 2025 reached $0.01, down 99.8%, while the annual FY2025 figure was $0.01, 99.8% down from the prior year.
  • Debt to Equity was $0.01 for Q4 2025 at Bioharvest Sciences, down from $2.94 in the prior quarter.
  • Across five years, Debt to Equity topped out at $2.94 in Q4 2024 and bottomed at -$0.01 in Q4 2023.
  • The 3-year median for Debt to Equity is $0.01 (2025), against an average of $0.98.
  • Year-over-year, Debt to Equity surged 46711.83% in 2024 and then crashed 99.8% in 2025.
  • Over 3 years, Debt to Equity stood at -$0.01 in 2023, then surged by 46711.83% to $2.94 in 2024, then crashed by 99.8% to $0.01 in 2025.
  • The last three reported values for Debt to Equity were $0.01 (Q4 2025), $2.94 (Q4 2024), and -$0.01 (Q4 2023) per Business Quant data.